Predict your next investment

Diagnoz company logo
MOBILE & TELECOMMUNICATIONS | Mobile Software & Services / Healthcare
diagnoz.me

See what CB Insights has to offer

Founded Year

2017

About Diagnoz

Diagnoz is developing a home diagnostic kit for microbial infections. Its solution is a disposable unit that facilitates treatment by turning any smartphone into a medical-grade diagnostic microscope.

Diagnoz Headquarter Location

High Tech Village Givat Ram

Jerusalem,

Israel

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Diagnoz

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Diagnoz is included in 3 Expert Collections, including Health & Wellness Assessment.

H

Health & Wellness Assessment

3,336 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance

I

Infectious Disease

2,226 items

Entities aiding the surveillance, screening, prevention, diagnosis, treatment, and containment of infections & the maintenance of public wellbeing during outbreaks.

T

Telehealth

2,617 items

Companies developing, offering, or using electronic and telecommunication technologies to facilitate the delivery of health & wellness services from a distance. *Columns updated as regularly as possible; priority given to companies with the most and/or most recent funding.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.